Our Sites in Singapore
Tuas Manufacturing Site
Located within Tuas Biomedical Park, Pfizer’s Active Pharmaceutical Ingredients (API) manufacturing plant started operations in 2003. The site covers about 22 acres and employs close to 400 colleagues.
Environmental, Health and Safety is our priority and we have systems in place which safeguard the health and well-being of our colleagues and the communities around us and comply with all regulatory and legal requirements.
We are committed to the delivery of safe and effective products to patients. To meet this commitment, we maintain a quality-focused culture and ensure the highest priority is placed on the safety, efficacy and reliability of our products, and interactions with our stakeholders. Our leaders are committed to maintaining a strong quality culture with appropriate systems and processes in place to drive quality-focused behaviors and ensure decision making is based on what is best for product quality, patient safety, and the protection of Pfizer’s reputation and business.
We are among world’s premier biopharmaceutical companies, committed to ensuring manufacturing excellence, with state-of-the art facilities and best practices to deliver high quality products and services across the globe.
We believe that every colleague has a part to play in bringing breakthroughs that change patients’ lives. Our teams are skilled in manufacturing, logistics, planning, engineering, laboratory, quality, financial, digital and business operations.
Manufacturing Technology & Development Centre:
Established in 2016, the Pfizer Manufacturing Technology and Development Centre (MTDC) is located on Jurong Island. The MTDC is part of PGS Global Technology & Engineering Small Molecule Technology team and supports manufacturing operations across Pfizer’s global network.
Consisting of synthetic and analytical chemists and chemical engineers, the team focuses on providing innovative engineering and chemistry solutions to manufacturing sites globally. This often involves collaborating with large cross functional teams to resolve issues related to process robustness, capacity relief or waste reduction. The team strengths lie in Particle Engineering (Crystallization), Platform Technologies for Flow and Batch, and Predictive Modelling.
The MTDC also represents Pfizer in the Pharma Innovation Programme Singapore (PIPS), an industry-led platform which aims to synergistically and strategically bring together public sector research capabilities and domain expertise of the pharmaceutical industry to enhance the productivity and operational efficiency within Singapore’s pharmaceutical sector through leveraging novel manufacturing technologies and data analytics.
Singapore Lab Services:
Scientific and Laboratory Services (SLS) Singapore supports PGS by providing reference standards to Pfizer’s global network and our partners. We procure, establish, maintain and distribute reference standards required for release, stability and QC testing for more than 1,000 small molecules and focus on materials which are not commercially available and for multi-site use.